Lynx Capital Group’s Boston Scientific BSX Stock Holding History

Lynx Capital Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Hold	14,625	–	–	0.25%	64
2026 Q1	$918K	Hold	14,625	–	–	0.43%	57
2025 Q4	$1.39M	Hold	14,625	–	–	0.64%	52
2025 Q3	$1.43M	Hold	14,625	–	–	0.66%	50
2025 Q2	$1.57M	Hold	14,625	–	–	0.76%	51
2025 Q1	$1.48M	Hold	14,625	–	–	0.76%	47
2024 Q4	$1.31M	Hold	14,625	–	–	0.75%	49
2024 Q3	$1.23M	Sell	14,625 -700	-5%	-$55.2K	0.79%	47
2024 Q2	$1.18M	Hold	15,325	–	–	0.82%	45
2024 Q1	$1.05M	Hold	15,325	–	–	0.71%	49
2023 Q4	$886K	Buy	+15,325	New	+$818K	0.65%	51

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lynx Capital Group's BSX Position: Q2 2026 in Review

Lynx Capital Group held its Boston Scientific (BSX) position steady in Q2 2026 at 14,625 shares worth $624K. The position accounts for 0.25% of the portfolio, ranked #64.

Lynx Capital Group first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.57M in Q2 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Lynx Capital Group held 14,625 shares of Boston Scientific worth $624K as of Q2 2026.
Lynx Capital Group left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.25% of Lynx Capital Group's portfolio in Q2 2026, its #64 holding.
Lynx Capital Group first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Lynx Capital Group's Boston Scientific position peaked at $1.57M in Q2 2025.
1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lynx Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.